Clinical Trials on HER2-low Expressing Breast Cancer
Total 11995 results
-
iOMEDICO AGSeagen Inc.RecruitingHER2-positive Breast CancerGermany, Austria
-
Xijing HospitalNot yet recruitingBreast Cancer | HER2-positive Breast Cancer
-
Breast Cancer Trials, Australia and New ZealandRecruitingBreast Cancer | HER2-positive Breast CancerAustralia
-
University of UtahRecruitingHER2-negative Breast CancerUnited States
-
Fudan UniversityRecruitingHER2-positive Breast CancerChina
-
Genor Biopharma Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHER2-positive Breast CancerChina
-
New Mexico Cancer Care AllianceRecruitingHER2 Negative Breast CancerUnited States
-
Centre Jean PerrinRecruitingHER2 Positive Breast CancerFrance
-
Shanghai Henlius BiotechActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Breast CancerChina
-
Daiichi SankyoCompletedHER2-positive Breast CancerSpain, Ireland, Italy
-
Jazz PharmaceuticalsActive, not recruitingHER2+/HR+ Breast CancerUnited States, Spain, Canada
-
University of RochesterSuspendedHER2-positive Breast CancerUnited States
-
Armando GiulianoWithdrawnBreast Cancer | HER2-positive Breast CancerUnited States
-
Puma Biotechnology, Inc.CompletedHER2 Amplified Breast CancerPortugal
-
Institut Claudius RegaudTerminated
-
Dorte NielsenTerminated
-
Cancer Institute and Hospital, Chinese Academy...First Affiliated Hospital Xi'an Jiaotong University; Wuhan Union Hospital,... and other collaboratorsUnknownHER2-negative Breast CancerChina
-
Seagen Inc.ParexelApproved for marketing
-
Henan Cancer HospitalUnknown
-
Hebei Medical University Fourth HospitalUnknown
-
Western Regional Medical CenterTerminated
-
Merrimack PharmaceuticalsTerminatedBreast Cancer | HER2 Positive Breast CancerSpain, United States, Italy, France, Canada, Belgium, Austria, Germany, Czech Republic
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands
-
Mayo ClinicRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | Hormone-receptor-positive Breast CancerUnited States
-
Ruth O'ReganUniversity of Rochester; Puma Biotechnology, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast CancerUnited States
-
Novartis PharmaceuticalsRecruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingHER2-positive Advanced Breast Cancer
-
Beijing 302 HospitalNot yet recruitingHR+/HER2- Advanced Breast CancerChina
-
Peking University People's HospitalRecruitingHER2-negative Early Breast CancerChina
-
Peking University People's HospitalRecruitingHER2-positive Early Breast CancerChina
-
Institut CurieRecruitingHER2-negative Metastatic Breast CancerFrance
-
Hoffmann-La RocheActive, not recruiting
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerJapan
-
Liaoning Tumor Hospital & InstituteCompletedHER2-positive Metastatic Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterHoffmann-La Roche; Genentech, Inc.; Hartford HealthCareActive, not recruitingMetastatic HER2-Positive Breast CancerUnited States
-
Shanghai Institute Of Biological ProductsFudan UniversityCompletedHER2-positive Early Breast CancerChina
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedFemale | HER2-positive Breast CancerRussian Federation
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHER2 Positive Metastatic Breast CancerChina
-
Bio-Thera SolutionsUnknownHER2-positive Advanced Breast CancerChina
-
AstraZenecaCompletedER+ HER2- Advanced Breast CancerUnited States, United Kingdom, Korea, Republic of
-
German Breast GroupBoehringer IngelheimCompleted
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
Cancer Trials IrelandTerminatedMetastatic Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast CancerIreland, Spain
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompleted
-
Fudan UniversityNot yet recruitingNeoadjuvant Therapy | Early Breast Cancer | HR+HER2- Breast Cancer
-
University of MiamiRecruitingStage IV Breast Cancer | HER2-positive Metastatic Breast CancerUnited States
-
Inova Health Care ServicesCity of Hope Medical CenterRecruitingBreast Cancer | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Wisconsin, MadisonRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-negative Breast CancerUnited States
-
Novartis PharmaceuticalsTerminatedMetastatic Breast Cancer | HER2+ Breast CancerBelgium, France, Spain, United States, United Kingdom, Italy